Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Peptides / GHRH analogues

181 In the index

Tesamorelin + Ipamorelin TESA/IPA

A combination pairing tesamorelin with ipamorelin, another growth-hormone-related peptide, meant to boost growth hormone more than either alone. Tesamorelin's own approved-use trials support its benefits, but this specific combination hasn't been formally studied in humans.

Also known as Blend

Effects Build muscle Lose fat
Routes Subcutaneous
Legal status Research chemical
WADA Banned at all times

Molecular Structure of C221H366N72O67S

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Nitrogen
  • Oxygen
  • Sulfur

Chemistry

Formula
C221H366N72O67S
Molar mass
5136
CAS
218949-48-5
PubChem CID
16137828

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Tesamorelin 1-2 mg + Ipamorelin 100-200 mcg, combined
Reported range Varies by vendor/clinic protocol
Route Subcutaneous injection
Frequency Once daily
Duration Ongoing (unregulated/clinic use)

Tesamorelin's own approved-use trials support its individual benefits, but this specific combination with ipamorelin has not been formally studied in humans.

Where this comes from FDA prescribing information (tesamorelin only); user-reported/clinic literature (combination)

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.